The U.S. stock market should open a very slight decline on Thursday. The index futures are predicting a small opening in lower indices on Wall Street. Futures on the Standard & Poor's 500 symbolically retreating from 0.02% to 1 081.50 points and those on the Nasdaq 100 grappillent 0.04% to 1 820.50 points. On Wednesday, the NYSE boosted by the publication of an indicator better than expected U.S. manufacturing, which has eased concerns over the takeover led to depression of investors in August surged forward. The Dow, which fell 4.3% in August, its worst performance this month for nine years, rebounded 2.54% to 10,269 points.The Nasdaq gained 2.97% to 2177 points while the S & P advanced 2.95% to 1080 points.
On the foreign exchange market, the euro was up slightly against the dollar in the morning, but struggled to increase its gains amid anxiety before the monthly monetary policy decision of the European Central Bank (ECB) and on the eve the very important report on employment and unemployment in the United States. The European currency traded at 1.2819 dollars against 1.2807 dollars late Wednesday afternoon.
Overseas, a new set of indicators is the program on Thursday, pending the release of employment figures tomorrow.Investors await including weekly claims for unemployment benefits, the second estimate of productivity in the second quarter, industrial orders for July and the promises of home sales for the month of July.
On the side of values, the automotive sector should stand today. The month of August has actually been the worst for U.S. auto industry since 1983. Sales fell 21% to 11.47 million vehicles. Ford Motor has reported a sales decline of 11%. General Motors, which is preparing an offering of securities to reduce by nearly 61% of the state capital, reflecting a drop in its sales by 25%.
Always on the side of values, the U.S. computer giant Apple has unveiled the updated version of its iPod portable should be very surrounded.The Apple brand has also significantly lowered the price of its Apple TV boxes, for playback on a television screen high definition video from a computer.
Also note, Henri Termeer, the boss of the U.S. biotech Genzyme, acknowledged that his company sought after by Sanofi-Aventis is for sale. Genzyme is good to sell, "but not at $ 69 per share, or $ 18.5 billion in total, as proposed by the French said parton biotech.